Back to Directory

Cheryl Blanchette

Email

Phone

Institution

FHI 360

Role

Community Coordinator

Address

FHI360
359 Blackwell Street
Suite 200
Durham, NC 27701

Request an Update

Affiliated Studies

IMPAACT 2026: Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum

DAIDS Number

38609

Research Area

Treatment

Study Status

Pending

Locality

US & Non-US

P1078: TB APPRISE: TB Ante vs. Postpartum Prevention with INH in HIV Seropositive mothers and their Exposed infants

DAIDS Number

10732

Research Area

Tuberculosis

Study Status

Participants Off Study and Primary Analysis Completed

Locality

Non-US

IMPAACT 2001: A Phase I/II Trial of the Pharmacokinetics, Tolerability, and Safety of Once-Weekly Rifapentine and Isoniazid in HIV-1-infected and HIV-1-uninfected Pregnant and Postpartum Women with Latent Tuberculosis Infection

DAIDS Number

12026

Research Area

Tuberculosis

Study Status

Participants Off Study and Primary Analysis Completed

Locality

US & Non-US

IMPAACT 2002: Combined Cognitive Behavioral Therapy and a Medication Management Algorithm for Treatment of Depression among Youth Living with HIV in the United States

DAIDS Number

12051

Research Area

Complications & Comorbidities

Study Status

Participants Off Study and Primary Analysis Completed

Locality

United States

IMPAACT 2009 : Pharmacokinetics, Feasibility, Acceptability, and Safety of Oral Pre-Exposure Prophylaxis for Primary HIV Prevention during Pregnancy and Postpartum in Adolescents and Young Women and their Infants

DAIDS Number

30020

Research Area

Prevention

Study Status

Enrolling

Locality

Non-US

Show All